#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma metastatic Non-renal cell carcinoma of kidney Neuropathy peripheral Frontotemporal dementia Pyruvate kinase deficiency anaemia Deafness neurosensory Vulval cancer recurrent Cervix carcinoma recurrent Palmar-plantar erythrodysaesthesia syndrome Fontan procedure Congenital cystic kidney disease Atypical haemolytic uraemic syndrome Behcet's syndrome Adenoid cystic carcinoma Fibrosarcoma More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Basic Information Hepatic angiosarcoma – Diagnostics Lennox-Gastaut syndrome – Treatment Progressive supranuclear palsy – Basic Information Krabbe’s disease – Trials in Disease MELAS syndrome Leiomyosarcoma recurrent – Treatment Richter’s syndrome – Diagnostics Soft tissue sarcoma – Trials in Disease Angiosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taldefgrobep Alfa Opevesostat Histidine Tasipimidine Domperidone IMA401 Vibostolimab Cabergoline Rivaroxaban Relebactam Alectinib Hydrochloride Solrikitug Nirmatrelvir Enalapril TRONTINEMAB Linerixibat Ima402 Bemarituzumab Anhydrous Cidofovir Tryptophan More therapies…

    Learn about Your Condition

    Peripheral artery restenosis Lung adenocarcinoma stage IV Benign renal neoplasm Aortic valve stenosis Pancreatitis relapsing Rhinitis allergic Generalised anxiety disorder Oedema Undifferentiated sarcoma Bronchopulmonary aspergillosis Myotonia Fibrosarcoma metastatic Epileptic encephalopathy Critical illness Meniscus injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ischaemic stroke

  • Study on Imatinib for Improving Recovery in Patients with Acute Ischemic Stroke

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Imatinib
    • Imatinib Mesilate
    Sweden

  • Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Study of ApTOLL for Treating Acute Ischemic Stroke in Patients Before Hospital Arrival

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Aptamer-4Ft
    Spain

  • Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Redasemtide
    Belgium Czechia Denmark Finland France Germany +3

  • Study on the Effectiveness of Dornase Alfa for Improving Blood Flow in Patients with Ischemic Stroke Eligible for Thrombectomy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Dornase Alfa
    France

  • Study on Glenzocimab for Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy

    Not recruiting

    4 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Glenzocimab
    France
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!